If you were unable to join Alzheimer’s Disease International and missed their fireside chat on vaccines, you can catch-up now.
During this conversation between ADI’s Head of Research and Publications, Wendy Weidner and Andrea Pfeifer, Co-founder, CEO and Director of AC Immune SA, and Mei Mei Hu, Co-founder and CEO of Vaxxinity, they answered your questions around:
- Novel vaccine development and their mechanisms
- Safety and distribution challenges of future vaccines for dementia
- Evaluation of vaccines’ potential beyond Alzheimer’s disease to other health conditions, including other types of dementia and Down Syndrome
- The crucial role of public-private partnerships in ensuring equitable access to these vaccine
- Examination of late diagnosis scenarios and the potential benefits of these vaccines
- Optimism around the prospect of a successful vaccine before 2030
